Safety and Efficacy of C21 in Subjects With COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

July 21, 2020

Primary Completion Date

October 13, 2020

Study Completion Date

October 13, 2020

Conditions
COVID-19
Interventions
DRUG

C21

C21

DRUG

Placebo

Placebo

Trial Locations (9)

290022

First Floor Clinical Research Department Rhythm Heart Institute, Vadodara

380016

Department of Medicine, Civil Hospital and B J Medical College, Ahmedabad

395001

Infectious Disease, Metas Adventist Hospital, Surat

395010

Clinical Research Department, Basement, Unity Trauma Centre and ICU (Unity Hospital, Surat

400016

Internal Medicine S.L. Raheja Hospital, Mumbai

411001

Neuro Critical Care, Grant Medical Foundation Ruby Hall Clinic, Pune

440003

Department of Medicine, Government Medical College and Hospital, Nagpur

Unknown

Department of Medicine, Noble Hospitals Pvt. Ltd, Pune

WC1E 6BT

Respiratory Medicine, University College Hospital, London

All Listed Sponsors
collaborator

Orphan Reach Ltd.

INDUSTRY

lead

Vicore Pharma AB

INDUSTRY

NCT04452435 - Safety and Efficacy of C21 in Subjects With COVID-19 | Biotech Hunter | Biotech Hunter